News

Bristol-Myers Squibb: Great Dividend But Questionable Growth Prospects
Bristol-Myers Squibb faces revenue declines but offers long-term potential via growth drugs. Read what BMY stock has to offer ...
Are Options Traders Betting on a Big Move in Bristol-Myers Squibb Stock?
Investors in Bristol-Myers Squibb Company BMY need to pay close attention to the stock based on moves in the options market lately. That is because the July 18, 2025 $25 Call had some of the highest ...
BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock?
Shares of this biotech giant have lost 16.3% year to date compared with the industry’s decline of 2.7%. The sto ...
Bristol-Myers Squibb: You Might Wish You Bought More Now (Upgrade)
Discover why Bristol-Myers Squibb's undervalued stock, strong cash flow, and 5% dividend yield make it an attractive buy ...